2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$58.93+$0.31 (+0.54%)
Price as of Sep 11, 2026 7:30 PM EDT- $26.0BMarket Cap
- 64.32%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$58.93+$0.31 (+0.54%)
RPRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $58.61 | ||
Change | -$0.14 (-0.24%) | ||
Open | $58.95 | ||
High | $59.54 | ||
Low | $58.35 | ||
Previous Close | $58.75 | ||
Volume | 2,596,068 | ||
30-Day Average Volume | 2,965,980 | ||
1-Week Change | -8.36% | ||
1-Month Change | 1.83% | ||
1-Year Change | 64.32% | ||
3-Year Change | 118.04% | ||
5-Year Change | 71.19% | ||
Fundamentals | |||
Shares Outstanding | 443.2M | ||
Total Assets | $19.8B | ||
Market Cap | $26.0B | ||
Enterprise Value | $34.1B | ||
Period: QTR TTM FY | |||
Revenue | $638.0M | ||
Net Income | $17.9M | ||
Free Cash Flow | $728.5M | ||
EBIT | $17.9M | ||
EBITDA | $19.2M | ||
Net Working Capital | $1.1B | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 1,779 | ||
Enterprise Value/Revenue | 53 | ||
P/B | 3 | ||
P/E | 1,465 | ||
PEG | -16 | ||
Price/Free Cash Flow | 36 | ||
Price/Operating Cash Flow | 36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.60% | ||
Trailing Annual Dividend Yield | 1.58% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 10/15/2010 | ||
Earnings & Revenue
Annual Dividend Yield